Literatur
-
1
Rösch W, Blum A L.
Volkskrankheit Sodbrennen. Vom „pathologischen Reflux” zur Refluxoesophagitis.
Dtsch Ärztebl.
1993;
90
C127-132
-
2
Atkinson M, Syiftikhar J PD, Robertson L S. et al .
The early diagnosis of oesophageal adenocarcinoma by endoscopic screening.
Eur J Cancer Prev.
1992;
1
327-330
-
3
Cameron A J, Lomboy C T, Pera M. et al .
Adenocarcinoma of the esophagogastric junction and Barrett’s esophgagus.
Gastroenterology.
1995;
109
1541-1546
-
4
Hameetemann W, Tytgat G NJ, Houthoff H J. et al .
Barrett’s esophagus: development of dysplasia and adenocarcinoma.
Gastroenterology.
1989;
96
1249-1256
-
5
Polepalle S, Callum R W.
Barrett’s esophagus: Current assessment and future perspectives.
Gastroenterol Clin North Am.
1990;
19
733-744
-
6
Sampliner R, Mackel C, Fennerty M B. et al .
Prospective incidence of cancer in Barrett’s esophagus.
Gastroenterology.
1991;
100
A153
-
7
Karras D J, Michalos A.
Importance of endoscopic surveillance in Barrett’s esophagus.
Gastroenterology.
1991;
100
A95
-
8
Böhmer C J, Hop W CJ, Meuwissen S GM. et al .
Carcinoma of Barrett’s esophagus, do smoking and alcohol really matter?.
Gastroenterology.
2000;
118
A459
-
9
Shaheen N J, Crosby M A, Bozymski E M. et al .
Is there a publication bias in the reporting of cancer risk in Barrett’s esophagus?.
Gastroenterology.
2000;
119
333-338
-
10
Jankowski J A, Provenzale D, Moayyedi P.
Esophageal adenocarcinoma arising from Barrett’s metaplasia has regional variations in the West.
Gastroenterology.
2002;
122
588-589
-
11
Jankowski J A, Harrison R F, Perry I. et al .
Barrett’s metaplasia.
Lancet.
2000;
356
2079-2085
-
12
Montgomery E, Bronner M P, Greenson J K. et al .
Are ulcers a marker for invasive carcinoma in Barrett’s esophagus? Data from a diagnostic variability study with clinical follow-up.
Am J Gastroenterol.
2002;
97
27-31
-
13
Weston A P, Badr A S, Hassanein R S.
Prospective multivariante analysis of clinical, endoscopic and histologic factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma.
Am J Gastroenterol.
1999;
94
3413-3419
-
14
Schnell, Sontag S J, Chejfec G. et al .
Long-term nonsurgical management of Barrrett’s esophagus with high-grade dysplasia.
Gastroenterology.
2001;
120
1607-1619
-
15
Vieth M, Stolte M.
Barrett’s esophagus and neoplasia: Data from the Bayreuth Barrett’s archive.
Gastroenterology.
2002;
122
590
-
16
Buttar N S, Want K K, Sebo T J.
Extent of high grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma.
Gastroenterology.
2001;
120
1630-1639
-
17
Robertson C S, Mayberry I F, Nicholson D A.
Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s oesophgaus.
Br J Surg.
1988;
75
760-763
-
18
Miros M, Kerlin P, Walker N.
Only patients with dysplasia progress to andocarcinoma in Barrett’s oesophagus.
Gut.
1991;
32
1441-1446
-
19
Reid B, Levine D, Longton G.
Predictors of progression to cancer in Barrett’s esophagus: Baseline histology and flow cytometry identify low and high risk patient subsets.
Am J Gastroenterology.
2000;
95
1669-1676
-
20
Inadomi J M, Sampliner R, Lagergren J. et al .
Cost-effectiveness of screening and surveillance of Barrett’s esophagus: more targeted screening, less surveillance!.
Gastroenterology.
2002;
122
A287
-
21
Stolte M, Vieth M.
Fondement histopathologique des modifications de la muqueuse oesophagienne. Ce que l’endoscopiste peut (et doit) voir.
Acta Endoscopica.
2001;
31
125-129
-
22
Schulz H, Miehlke S, Antos D. et al .
Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.
Gastrointest Endosc.
2000;
51
659-663
-
23
Sampliner R. and the Practice Parameters Committee of the American College of Gastroenterology .
Practice Guidelines on the Diagnosis, Surveillance, and Therapy of Barrett’s Esophagus.
Am J Gastroenterol.
1998;
93
1028-1032
-
24
Ell C, May A, Gossner L.
Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett’s esophagus.
Gastroenterology.
2000;
118
670-677
-
25
Sampliner R E. and the Practice Parameters Committee of the American College of Gastroenteroloy .
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus.
Am J Gastroenterol.
2002;
97
1888-1895
-
26
Van Sandick J W, van Lanschot J JB, Tytgat G NJ. et al .
The impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and postoperative survival of Barrett’s carcinoma.
Gut.
1998;
43
216-222
-
27
Streitz J M Jr, Andrews C W Jr, Ellis F H Jr.
Endoscopic surveillance of Barrett’s esophagus. Does it help?.
J Thorac Cardiovasc Surg.
1993;
105
383-388
-
28
Peters J H, Clark G WP, Ireland A P. et al .
Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients.
J Thorac Cardiovasc Surg.
1994;
108
813-822
-
29
Corley D A, Levin T R, Habel L A. et al .
Surveillance and survival in Barrett’s adenocarcinomas: A population-based study.
Gastroenterology.
2002;
122
633-640
Prof. Dr. M. Stolte
Institut für Pathologie, Klinikum Bayreuth
Preuschwitzer Straße 101
95445 Bayreuth
